ALLMedicine™ Liver Transplants Center

Sep 15th, 2020 - We report our experience utilizing liver donors with HCV Viremia (RNA+) for HCV negative recipients (HCV D+R-) at a Veterans Affairs (VA) transplant center. In 2018 we introduced an informed consent process for HCV D+R- liver transplants. Eight HC...

Sep 15th, 2020 - Early extubation of liver transplantation recipients is a cornerstone of Fast Track (FT) pathways. Identifying suitable candidates has previously been accomplished using peri-operative variables to develop a FT probability score. The objective of ...

Sep 3rd, 2020 - Understanding the mechanisms involved in immune protection provided by a hepatic allograft is imperative as further therapies for highly sensitized patients could be developed and thus expanding the donor pool and improving outcomes. The clinical ...

Aug 30th, 2020 - To identify post-liver transplant CT findings which predict graft failure within 1 year. We evaluated the CT scans of 202 adult liver transplants performed in our institution who underwent CT within 3 months after transplantation. We recorded CT f...

Aug 29th, 2020 - The COVID-19 pandemic is an emergency worldwide. In Italy, liver transplant activity was carried on, but despite all efforts, a 25% reduction of procured organs has already been observed during the first 4 weeks of the outbreak. To analyze if our ...

Dec 31st, 2012 - Liver disease is the twelfth commonest cause of mortality in adults in the United States, resulting in 34,000 deaths annually from cirrhosis. 7 In addition, the rising incidence of HCC in the United States is reflected in an increasing number of de.

Sep 15th, 2020 - We report our experience utilizing liver donors with HCV Viremia (RNA+) for HCV negative recipients (HCV D+R-) at a Veterans Affairs (VA) transplant center. In 2018 we introduced an informed consent process for HCV D+R- liver transplants. Eight HC...

Sep 15th, 2020 - Early extubation of liver transplantation recipients is a cornerstone of Fast Track (FT) pathways. Identifying suitable candidates has previously been accomplished using peri-operative variables to develop a FT probability score. The objective of ...

Sep 3rd, 2020 - Understanding the mechanisms involved in immune protection provided by a hepatic allograft is imperative as further therapies for highly sensitized patients could be developed and thus expanding the donor pool and improving outcomes. The clinical ...

Aug 30th, 2020 - To identify post-liver transplant CT findings which predict graft failure within 1 year. We evaluated the CT scans of 202 adult liver transplants performed in our institution who underwent CT within 3 months after transplantation. We recorded CT f...

Aug 29th, 2020 - The COVID-19 pandemic is an emergency worldwide. In Italy, liver transplant activity was carried on, but despite all efforts, a 25% reduction of procured organs has already been observed during the first 4 weeks of the outbreak. To analyze if our ...

Apr 1st, 2020 - In liver transplant recipients or patients with autoimmune hepatitis on immunosuppressive therapy, acute cellular rejection or disease flare should not be presumed in the face of active coronavirus disease 2019 (COVID-19), according to the America.

Dec 16th, 2019 - (Reuters) - Gilead Sciences Inc said on Monday all combinations of its three drugs to treat NASH were unsuccessful in a mid-stage study, the latest failure in a string of trials seeking to develop the first approved treatment for the fatty liver d...

Nov 6th, 2019 - Liver transplant for the three predominant autoimmune liver diseases – primary biliary cholangitis, primary sclerosing cholangitis, and autoimmune hepatitis – has been known to have favorable outcomes overall, but little evidence comparing cholang.

Jun 19th, 2019 - (Reuters Health) - Lack of knowledge among community physicians may be keeping them from raising the possibility of living donor transplants with their patients with liver disease, new survey data suggest. And misperceptions among the general publ...

Jan 22nd, 2019 - The proportion of U.S. liver transplants for alcoholic liver disease (ALD) rose steadily from 2002 to 2016, making ALD the leading indication for liver transplant, researchers reported. In 2002, ALD accounted for 24.2% of all U.S. liver transplant...